LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Response to the European Commission Call for Evidence for the EU Startup and Scaleup Strategy

    18/03/2025

    PUBLIC CONSULTATION

    EuropaBio, representing European biotechnology companies, welcomes the opportunity to contribute to the EU Startup and Scaleup Strategy call for evidence. Through its national associations and SME Platform, EuropaBio represents over 4500 biotech small and medium-sized companies, including startups and scaleups.

    For the full document and all references, please download the document below.

    EuropaBio Response to the European Commission Call for Evidence for the EU Startup and Scaleup Strategy


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    03/04/2026

    Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture


    Read more
    02/04/2026

    The EU Biotech Act II: A vital Act for biomanufacturing in Europe


    Read more
    31/03/2026

    Nestlé joins EuropaBio: Driving Innovation for Sustainable Food Systems


    Read more

    Important links

    • Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture
    • The EU Biotech Act II: A vital Act for biomanufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.